✦ LIBER ✦

The Role of Combination Therapy for Hypertension After ACCOMPLISH

✍ Scribed by Daniel T. Lackland

Book ID: 107617162
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 122 KB
Volume: 4
Category: Article
ISSN: 1932-9520
DOI: 10.1007/s12170-010-0101-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sevikar®: Combination therapy for the tr

Sevikar®: Combination therapy for the treatment of hypertension

✍ Eduardo Pimenta 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 49 KB

Sevikar®: combination therapy for the tr

Sevikar®: combination therapy for the treatment of hypertension

✍ Eduardo Pimenta 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 224 KB

Evolving strategies for the use of combi

Evolving strategies for the use of combination therapy in hypertension

✍ Alan H. Gradman; Celso Acevedo 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 345 KB

Role of combination therapy in the treat

Role of combination therapy in the treatment of hypertension: Focus on valsartan plus amlodipine

✍ Claudio Ferri; Giuseppe Croce; Giovambattista Desideri 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 420 KB

Role of vasobilation in the antihyperten

Role of vasobilation in the antihypertensive and antianginal effects of labetalol: Implications for therapy of combined hypertension and angina

✍ Lionel H. Opie 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 744 KB

Beta-adrenergic blockade is established therapy in the management of both hypertension and angina pectoris. This review evaluates the use of combined alpha-adrenergic and beta-adrenergic blockade for these conditions, with reference to labetalol. There are three major differences between labetalol a

The role of aldosterone in resistant hyp

The role of aldosterone in resistant hypertension: Implications for pathogenesis and therapy

✍ Murray Epstein; David A. Calhoun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 204 KB